CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024. In the quarter to June 2026, revenue grew 52.2%, EPS grew 1,443.8% and free cash flow grew 223.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

63.81 2.87 −4.30%
Market cap
$3.5B
P/E
29.7×
Fwd P/E
2,967×
Dividend yield
—
F-score
5/9
Altman Z
4.14
Beneish M
−3.36
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 5 6 8
ROE
24.11% (6.27%) (2.36%) 29.49%
ROA
15.50% (4.72%) (1.82%) 22.72%
ROIC
31.88% (15.28%) (8.02%) 130.06%
Return on Tangible Assets
30.36% (10.66%) (3.67%) 30.64%
Average Days of Receivables
48.78 40.97 39.42 27.39
Free Cash Flow per Share
0.68 0.65 1.27 1.65
Free Cash Flow
35.52 34.55 64.85 84.71
Other line items

Show all line items

Columns are period end dates